Peer-reviewed veterinary case report
Fast test to detect Babesia rossi and Babesia vogeli in dogs
By Troskie, Milana et al.·Published in Ticks and tick-borne diseases·2019·Department of Veterinary Tropical Diseases·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Development and validation of a multiplex, real-time PCR assay for Babesia rossi and Babesia vogeli.
- Species:
- dog
Plain-English summary
A new test has been developed to quickly and accurately diagnose babesiosis, a serious tick-borne disease affecting dogs in southern Africa. This disease is caused by parasites called Babesia rossi and Babesia vogeli, which can be hard to detect, especially when the infection is low. The new test can identify these parasites with high sensitivity and specificity, meaning it can confirm infections early and help vets start treatment sooner. This could lead to faster recovery for dogs suffering from this illness.
People also search for: dog babesiosis symptoms · Babesia rossi treatment · tick disease in dogs · how to test for Babesia in dogs
Abstract
Canine babesiosis is caused by tick-transmitted intraerythrocytic protozoan parasites occurring worldwide. In southern Africa, babesiosis is caused by Babesia rossi and B. vogeli and is one of the most common and important infectious diseases affecting dogs. There is no reliable, rapid and sensitive method for the detection of these parasites, especially when parasitaemia is low. The aim of this study was to develop a sensitive and specific multiplex TaqMan® MGB PCR assay for the diagnosis of canine babesiosis infections occurring in southern Africa, and to discriminate between Babesia rossi and B. vogeli. The fitness of purpose of the assay was to confirm diagnosis of suspect or clinical cases, and estimate prevalence of infection for research purposes. A total of 648 published sequences were used to design the assay. A set of group-specific canine Babesia spp. primers were designed to amplify a 117 nucleotide region of the 18S rRNA gene of all canine Babesia spp. Species-specific TaqMan® MGB probes were developed for B. rossi, B. vogeli, B. canis and B. gibsoni, but analytical validation was only performed for B. rossi and B. vogeli as a multiplex assay. The assay had a broad dynamic range and amplified B. rossi and B. vogeli efficiently (98.6% and 94.7% respectively). The assay was sensitive, with a 95% LOD of 10% parasitized erythrocytes (PE) for B. rossi and 10% PE for B. vogeli, and specific, with no cross reaction between B. rossi and B. vogeli and no detection of other haemoparasites that infect dogs, such as Ehrlichia canis and Anaplasma platys. Consistent repeatability within and between PCR runs was shown. This assay will be able to accurately and rapidly confirm babesiosis in canines and allow for treatment to be administered in the early stages of the disease, speeding up the recovery time in affected dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/30591405/